Skip to content

Insider · CIK 0001566630

Michael F. Goodrich

officer

Files at INTT (INTEST CORP). First filing -, latest -.

In brief

Michael F. Goodrich files SEC Form 4 as officer at INTT (INTEST CORP). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Michael F. Goodrich has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 13 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 16, 2026INTT
INTEST CORP
AGrant or award
Common Stock
+1,843$0.00$021,528Mar 18, 2026
Mar 16, 2026INTT
INTEST CORP
AGrant or award
Common Stock
+1,843$0.00$023,371Mar 18, 2026
Mar 17, 2026INTT
INTEST CORP
FTax withholding
Common Stock
-216$14.46$3,12323,155Mar 18, 2026
Mar 16, 2026INTT
INTEST CORP
AGrant or award
Employee Stock Option (right to buy)derivative
+3,116$0.00$03,116Mar 18, 2026
Mar 6, 2026INTT
INTEST CORP
FTax withholding
Common Stock
-148$13.24$1,96019,685Mar 10, 2026
Mar 17, 2025INTT
INTEST CORP
AGrant or award
Common Stock
+3,446$0.00$016,387Mar 19, 2025
Mar 17, 2025INTT
INTEST CORP
AGrant or award
Common Stock
+3,446$0.00$019,833Mar 19, 2025
Mar 17, 2025INTT
INTEST CORP
AGrant or award
Employee Stock Option (right to buy)derivative
+1,172$4.61$5,4031,172Mar 19, 2025
Mar 17, 2025INTT
INTEST CORP
AGrant or award
Employee Stock Option (right to buy)derivative
+5,785$0.00$05,785Mar 19, 2025
Mar 6, 2024INTT
INTEST CORP
AGrant or award
Common Stock
+2,356$0.00$010,587Mar 8, 2024
Mar 6, 2024INTT
INTEST CORP
AGrant or award
Common Stock
+2,354$0.00$012,941Mar 8, 2024
Mar 6, 2024INTT
INTEST CORP
AGrant or award
Employee Stock Option (right to buy)derivative
+4,068$0.00$04,068Mar 8, 2024
Jan 16, 2024INTT
INTEST CORP
AGrant or award
Common Stock
+8,231$0.00$08,231Jan 18, 2024

Questions about Michael F. Goodrich

Answered from the filings on this page, as of the latest one.

Is Michael F. Goodrich buying or selling?

Michael F. Goodrich has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Michael F. Goodrich's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael F. Goodrich has 0.

Where does Michael F. Goodrich file Form 4?

Michael F. Goodrich has filed Form 4 at INTT (INTEST CORP) as Division Pres-Process Tech. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Michael F. Goodrich: insider trades and track record | InsiderTell